Table of Contents
Journal of Biomarkers
Volume 2014, Article ID 272683, 8 pages
http://dx.doi.org/10.1155/2014/272683
Research Article

A Panel of Cancer Testis Antigens and Clinical Risk Factors to Predict Metastasis in Colorectal Cancer

1Division of Medical Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB), Pajoohesh Boulevard, Tehran-Karaj Highway, 17th Km, P.O. Box 14965-161, Tehran, Iran
2Department of Genetics, Faculty of Science, Shahid Chamran University, Ahwaz, Iran
3Hazrat Rasool Hospital, Tehran University of Medical Sciences and Health Care Services, Tehran, Iran

Received 20 August 2013; Revised 30 January 2014; Accepted 31 January 2014; Published 9 March 2014

Academic Editor: Charles Frederick Streckfus

Copyright © 2014 Ramyar Molania et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. A. Haggar and R. P. Boushey, “Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors,” Clinics in Colon and Rectal Surgery, vol. 22, no. 4, pp. 191–197, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. N. C. Bird, D. Mangnall, and A. W. Majeed, “Biology of colorectal liver metastases: a review,” Journal of Surgical Oncology, vol. 94, no. 1, pp. 68–80, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. W. J. H. J. Meijerink, M. H. G. M. Van Der Pas, D. L. Van Der Peet, M. A. Cuesta, and S. Meijer, “New horizons in colorectal cancer surgery,” Surgical Endoscopy and Other Interventional Techniques, vol. 23, no. 1, pp. 1–3, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. B. Nordlinger, M.-A. Quilichini, and R. Parc, “Hepatic resection for colorectal liver metastases: influence on survival of preoperative factors and surgery for recurrences in 80 patients,” Annals of Surgery, vol. 205, no. 3, pp. 256–263, 1987. View at Google Scholar · View at Scopus
  5. G. P. Kanas, A. Taylor, J. N. Primrose et al., “Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors,” Journal of Clinical Epidemiology, vol. 4, pp. 283–301, 2012. View at Google Scholar
  6. T. Ruers and R. P. Bleichrodt, “Treatment of liver metastases, an update on the possibilities and results,” European Journal of Cancer, vol. 38, no. 7, pp. 1023–1033, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Weitz, P. Kienle, A. Magener et al., “Detection of disseminated colorectal cancer cells in lymph nodes, blood and bone marrow,” Clinical Cancer Research, vol. 5, no. 7, pp. 1830–1836, 1999. View at Google Scholar · View at Scopus
  8. Z. Chen, M. Li, Y. Yuan, Q. Wang, L. Yan, and J. Gu, “Cancer/testis antigens and clinical risk factors for liver metastasis of colorectal cancer: a predictive panel,” Diseases of the Colon and Rectum, vol. 53, no. 1, pp. 31–38, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. P. M. S. Alves, N. Lévy, H. Bouzourene et al., “Molecular and immunological evaluation of the expression of cancer/testis gene products in human colorectal cancer,” Cancer Immunology, Immunotherapy, vol. 56, no. 6, pp. 839–847, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. F. Bettoni, F. C. Filho, D. M. Grosso et al., “Identification of FAM46D as a novel cancer/testis antigen using EST data and serological analysis,” Genomics, vol. 94, no. 3, pp. 153–160, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. J. J. Kim, K. Rajagopalan, B. Hussain et al., “CETN1 is a cancer testis antigen with expression in prostate and pancreatic cancers,” Biomarker Research, vol. 1, article 22, 2013. View at Google Scholar
  12. E. Fratta, S. Coral, A. Covre et al., “The biology of cancer testis antigens: putative function, regulation and therapeutic potential,” Molecular Oncology, vol. 5, no. 2, pp. 164–182, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Chiriva-Internati, Y. Yu, L. Mirandola et al., “Identification of AKAP-4 as a new cancer/testis antigen for detection and immunotherapy of prostate cancer,” Prostate, vol. 72, no. 1, pp. 12–23, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Mirandola, M. J. Cannon, E. Cobos et al., “Cancer testis antigens: novel biomarkers and targetable proteins for ovarian cancer,” International Reviews of Immunology, vol. 30, no. 2-3, pp. 127–137, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. M. van Duin, A. Broyl, Y. de Knegt et al., “Cancer testis antigens in newly diagnosed and relapse multiple myeloma: prognostic markers and potential targets for immunotherapy,” Haematologica, vol. 96, no. 11, pp. 1662–1669, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. L. G. Almeida, N. J. Sakabe, A. R. de Oliveira et al., “CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens,” Nucleic Acids Research, vol. 37, no. 1, pp. D816–D819, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. H. Cheng, E. W. Wong, and C. Y. Cheng, “Cancer/testis (CT) antigens, carcinogenesis and spermatogenesis,” Spermatogenesis, vol. 1, no. 3, pp. 209–220, 2011. View at Google Scholar
  18. F. F. Costa, K. Le Blanc, and B. Brodin, “Concise review: cancer/testis antigens, stem cells, and cancer,” Stem Cells, vol. 25, no. 3, pp. 707–711, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. M. J. Scanlan, A. O. Gure, A. A. Jungbluth, L. J. Old, and Y.-T. Chen, “Cancer/testis antigens: an expanding family of targets for cancer immunotherapy,” Immunological Reviews, vol. 188, pp. 22–32, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. M. J. Scanlan, A. J. G. Simpson, and L. J. Old, “The cancer/testis genes: review, standardization, and commentary,” Cancer Immunity, vol. 4, article 1, 2004. View at Google Scholar · View at Scopus
  21. L. Calabrò, E. Fonsatti, M. Altomonte et al., “Methylation-regulated expression of cancer testis antigens in primary effusion lymphoma: immunotherapeutic implications,” Journal of Cellular Physiology, vol. 202, no. 2, pp. 474–477, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. V. Gattei, E. Fonsatti, L. Sigalotti et al., “Epigenetic immunomodulation of hematopoietic malignancies,” Seminars in Oncology, vol. 32, no. 5, pp. 503–510, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Choi and H. Chang, “The expression of MAGE and SSX, and correlation of COX2, VEGF, and survivin in colorectal cancer,” Anticancer Research, vol. 32, no. 2, pp. 559–564, 2012. View at Google Scholar · View at Scopus
  24. A. G. Dakshinamurthy, R. Ramesar, P. Goldberg, and J. M. Blackburn, “Infrequent and low expression of cancer-testis antigens located on the X chromosome in colorectal cancer: Implications for immunotherapy in South African populations,” Biotechnology Journal, vol. 3, no. 11, pp. 1417–1423, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Hanafusa, A. E. A. Mohamed, S. Domae, E. Nakayama, and T. Ono, “Serological identification of Tektin5 as a cancer/testis antigen and its immunogenicity,” BMC Cancer, vol. 12, article 520, 2012. View at Google Scholar
  26. G. Almanzar, P. B. Olkhanud, M. Bodogai et al., “Sperm-derived SPANX-B is a clinically relevant tumor antigen that is expressed in human tumors and readily recognized by human CD4+ and CD8+ T cells,” Clinical Cancer Research, vol. 15, no. 6, pp. 1954–1963, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. B. M. Wolpin and R. J. Mayer, “Systemic treatment of colorectal cancer,” Gastroenterology, vol. 134, no. 5, pp. 1296–1310, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. A. J. G. Simpson, O. L. Caballero, A. Jungbluth, Y.-T. Chen, and L. J. Old, “Cancer/testis antigens, gametogenesis and cancer,” Nature Reviews Cancer, vol. 5, no. 8, pp. 615–625, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Odunsi, F. Qian, J. Matsuzaki et al., “Vaccination with an NY-ESO-1 peptide of HLA class I/II specificities induces integrated humoral and T cell responses in ovarian cancer,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 31, pp. 12837–12842, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. D. Atanackovic, N. K. Altorki, Y. Cao et al., “Booster vaccination of cancer patients with MAGE-A3 protein reveals long-term immunological memory or tolerance depending on priming,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 5, pp. 1650–1655, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Cascinu, V. Georgoulias, D. Kerr, T. Maughan, R. Labianca, and M. Ychou, “Colorectal cancer in the adjuvant setting: perspectives on treatment and the role of prognostic factors,” Annals of Oncology, vol. 14, supplement 2, pp. ii25–ii29, 2003. View at Google Scholar · View at Scopus
  32. T. Watanabe, T.-T. Wu, P. J. Catalano et al., “Molecular predictors of survival after adjuvant chemotherapy for colon cancer,” The New England Journal of Medicine, vol. 344, no. 16, pp. 1196–1206, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. K. W. Hunter, N. P. S. Crawford, and J. Alsarraj, “Mechanisms of metastasis,” Breast Cancer Research, vol. 10, no. 1, article S2, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. U. Kong, J. Koo, K. Choi, J. Park, and H. Chang, “The expression of GAGE gene can predict aggressive biologic behavior of intestinal type of stomach cancer,” Hepato-Gastroenterology, vol. 51, no. 59, pp. 1519–1523, 2004. View at Google Scholar · View at Scopus
  35. T. Shiraishi, N. Terada, Y. Zeng et al., “Cancer/Testis antigens as potential predictors of biochemical recurrence of prostate cancer following radical prostatectomy,” Journal of Translational Medicine, vol. 9, no. 1, article 153, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. Zeng, Y. He, F. Yang et al., “The cancer/testis antigen prostate-associated gene 4 (PAGE4) is a highly intrinsically disordered protein,” Journal of Biological Chemistry, vol. 286, no. 16, pp. 13985–13994, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Tammela, A. A. Jungbluth, F. Qian et al., “SCP-1 cancer/testis antigen is a prognostic indicator and a candidate target for immunotherapy in epithelial ovarian cancer,” Cancer Immunity, vol. 4, article 10, 2004. View at Google Scholar · View at Scopus